Erlotinib Side Effects | Medical Algorithm

Are you evaluating a patient for therapy with erlotinib?

Yes

Are you planning a high dose regimen?

Yes

Does/Is the patient?

• have peptic ulcer disease?

Yes

• have diverticulosis?

Yes

• being treated with an anti-angiogenic agent?

Yes

• receiving taxane-based therapy?

Yes

• being treated with corticosteroids?

Yes

• taking an NSAID?

Yes

• have a history of GI perforation associated with erlotinib?

Yes

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of risk factors for a gastrointestinal tract perforation

Is the patient a candidate for erlotinib therapy?

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Clinical Diagnosis, Including Family History For Genetics
- Daily Gut Score of Blijlevens et al for Gastrointestinal Toxicity Associated with Cancer Therapy
- Severe Long-Term Dysphagia Following Radiation Therapy for Head & Neck Cancer
Criteria For Diagnosis
- Criteria for Complicated & Uncomplicated Chemotherapy-Induced Diarrhea
Severity, Prognosis, Stage
Complications
- Management of Chemotherapy Induced Diarrhea

Therapy

Prevention
- Recommendations for Prevention of Chronic Radiation Enteritis
- Management of Chemotherapy Induced Diarrhea
Interventional Radiology
- Severe Long-Term Dysphagia Following Radiation Therapy for Head & Neck Cancer
- Risk Factors for Severe Long-Term Dysphagia Following Radiation Therapy for Head & Neck Cancer

Monitoring

Response To Therapy
- Severe Long-Term Dysphagia Following Radiation Therapy for Head & Neck Cancer
- Risk Factors for Severe Long-Term Dysphagia Following Radiation Therapy for Head & Neck Cancer
Adverse Effects

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Therapy

Monitoring

Specialty

Objective

ICD-10

Erlotinib (Tarceva) Treatment | Risk Factors for Gastrointestinal Perforation

Purpose: To identify risk factors for gastrointestinal perforation in a patient being treated with erlotinib (Tarceva).

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Therapy

Monitoring

Specialty

Objective

ICD-10